STEK — Stemtech Corp

OTC · Consumer Discretionary · Distributors · CIK 1511820 ·
Last close
$0.00
Market Cap
$14.6K
52W High
$0.00
52W Low
$0.00
ADV30
15,733,309
Next earnings
Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. The company's products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health. It offers rapid renew stem cell peptide night cream under the RCM System, stemrelease3, Stemflo MigraStem, OraStem, and Collect One brand name, as well as Cellect One shield hypochlorous acid skin care product. It serves through independent distributors Stemtech Corporation was founded in 2005 and is headquartered in Naples, Florida.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Sep 2025 852,300 682,483 -339,217 -809,406 3,755,801 255,416 10,301,779
Jun 2025 697,925 552,016 -300,988 -293,145 3,872,156 272,450 10,323,863
Mar 2025 868,046 720,264 -1,204,905 -1,455,591 3,754,250 305,836 9,437,421
Dec 2024 1,313,690 1,045,097 33,163 -396,580 3,782,245 255,298 9,009,050

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-1,630,290
Investing CF
$0
Financing CF
$642,803
CapEx
Dividends Paid
Buybacks
EPS Diluted TTM
$-0.03
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-33,395,464
Inventory
$234,614
Receivables
$326,487
ST Investments
EBIT TTM
$-1,592,830
Pretax Income TTM
$-2,964,127
Interest Exp TTM
$1,371,297
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$3,731,961
EBITDA
$-1,501,320
Free Cash Flow
$147,270
Enterprise Value
$3,893,012
Total Cash
$255,416
Total Debt
$4,870,994
Shares Out
146,176,902
Trailing EPS
$-0.02
Book Value
$-0.04
ROE
ROA
-30.6%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2024 5,053,690 -2,386,427 -3,769,566 3,782,245 9,009,050 -601,198
Dec 2023 4,921,531 -4,224,548 -5,430,245 3,683,271 6,462,036 -2,036,012
Dec 2022 4,559,399 -5,023,380 -8,544,923 4,266,941 7,438,859 -1,216,948
Dec 2021 4,321,245 -3,210,271 -7,077,463 5,720,122 9,725,568 -1,914,093

Peers — same industry

TickerNameMarket CapLastDaily %
BHATF Blue Hat Interactive Entertainment Technology $100.7K $0.03
CWPE CW Petroleum Corp $583.6K $0.03
STRG STARGUIDE GROUP, INC. $287 $0.00
DTCKF DAVIS COMMODITIES Ltd $847.1K $0.99
AHRO Authentic Holdings, Inc. $990.5K $0.00

News headlines (Yahoo Finance, 1h cache)

Stemtech Secures Inventory Funding
2026-04-07 12:30 · Yahoo
Stemtech Revolution 2026: A Bold New Era In Global Wellness
2026-03-18 12:30 · Yahoo
Stemtech Corporation Launches New Market Channel Biosciences Ecommerce
2026-02-26 13:30 · Yahoo
Stemtech Corporation Welcomes Dr. Zahooruddin To Life Sciences Advisory Board
2026-02-03 13:30 · Yahoo
Stemtech Corporation Appoints Dr. Lizette Leos, MD To Chief Scientific Officer (CSO)
2026-01-06 13:30 · Yahoo
Stemtech Corporation Announces Entry into China in a Joint Venture with Lightway Ventures
2025-12-02 13:30 · Yahoo
Stemtech Corporation - Stemtech Healthsciences India Pvt Ltd Announces Strategy for Market Entry
2025-10-27 12:30 · Yahoo
Stemtech Corporation Announces Entry Into India in a Joint Venture With Innoventure Dynamic LLP
2025-10-23 12:30 · Yahoo
Stemtech Corporation Backorders Filled
2025-10-20 12:30 · Yahoo
Stemtech Corporation Announces Exclusive Taiwan Distribution Licensing Agreement
2025-10-09 12:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.